← 產業報告目錄
Drug Discovery Market, By Drug Type (Small Molecule Drug and Biologics Drug), By Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics and Pharmacogenetics, Combinatorial Chemistry, Nanotechnology, Spectroscopy, Metabolomics, and Others), By Service (Drug Metabolism and Pharmacokinetics (DMPK) Services, Pharmaceutical Services, Chemical Services, and Biological Services), By End User (Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版商 Coherent Market Insights出版日期 2026-07-23頁數 257報告編號 CMR-3b23b78e4b
授權報價
| Single User Price | $4,500 USD |
| Site License Price | $7,000 USD |
| Enterprisewide Price (Global Site License) | $10,000 USD |
報告摘要
The Drug Discovery Market is estimated to be valued at USD 103.43 Bn in 2026 and is expected to reach USD 164.32 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033. The market is undergoing a major transformation mainly driven by rising prevalence of chronic diseases, increasing demand for novel therapeutics, and growing emphasis on precision medicine development initiatives. Drug discovery solutions, including target identification, hit generation, lead optimization, and preclinical evaluation platforms, enable pharmaceutical companies to identify compounds efficiently while addressing research complexity, development timelines, regulatory requirements, and safety standards. The market includes a wide array of discovery applications like oncology, neurology, infectious diseases, cardiovascular disorders, metabolic diseases, immunology, and rare disease research programs.
Pharmaceutical and biotechnology companies are focusing on advanced screening and research support to enhance accuracy, ensure regulatory compliance, and maintain development efficiency. The advancements in artificial intelligence, high-throughput screening, computational modeling, and biomarker analysis are improving discovery performance, especially in therapeutic areas with complex biological targets. In addition, the growing use of multi-omics data and collaborative research platforms helps optimize discovery workflows and resource utilization, thereby improving candidate selection and reducing development costs.
Market Dynamics
The market is witnessing major momentum owing to the increasing investment in pharmaceutical research, rising demand for first-in-class medicines, and the growing need for faster and more cost-efficient development pathways. The market’s growth is largely driven by pharmaceutical companies and research organizations seeking validated targets, differentiated molecules, and scalable discovery capabilities, especially in oncology, immunology, central nervous system disorders, metabolic diseases, and rare disease programs managing complex pipelines and high clinical attrition. Phenotypic screening, structural biology, laboratory automation, organoid models, and cloud-based research platforms play a central role in drug discovery, thereby helping improve biological understanding, accelerate compound evaluation, and support informed development decisions. The rising focus on drug repurposing, orphan medicines, and externally sourced innovation is strengthening the demand for specialized discovery services.
The expansion of biotechnology pipelines and contract research networks is fueling market growth. This is mainly driven by increasing outsourcing of early-stage studies, wider availability of screening libraries, and improved translational research and disease-modeling capabilities. Combination approaches involving academic collaboration, automated experimentation, and integrated data management help optimize research productivity and reduce discovery-stage failures.
The rising demand for differentiated therapeutic candidates is also propelling the market. Pharmaceutical developers, biotechnology firms, contract research organizations, academic institutes, and government laboratories play a crucial role in funding and conducting discovery programs. As awareness of collaborative research and translational validation grows, the market is expected to benefit from pipeline activity, improved candidate quality, and the development of targeted, scalable, and more clinically relevant therapeutic solutions.
Key Features of the Study
• This report provides in-depth analysis of the Drug Discovery Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Drug Discovery Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., GlaxoSmithKline LLC, Merck & Co. Inc., Agilent Technologies Inc., Eli Lilly and Company, F Hoffmann-La Roche Ltd, Bayer AG, Abbott Laboratories Inc., AstraZeneca PLC, and Shimadzu Corp.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Drug Discovery Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Drug Discovery Market
Market Segmentation
• By Drug Type (Revenue, USD Bn, 2021-2033)
o Small Molecule Drug
o Biologics Drug
• By Technology (Revenue, USD Bn, 2021-2033)
o High Throughput Screening
o Biochips
o Bioinformatics
o Pharmacogenomics and Pharmacogenetics
o Combinatorial Chemistry
o Nanotechnology
o Spectroscopy
o Metabolomics
o Others
• By Service (Revenue, USD Bn, 2021-2033)
o Drug Metabolism and Pharmacokinetics (DMPK) Services
o Pharmaceutical Services
o Chemical Services
o Biological Services
• By End User (Revenue, USD Bn, 2021-2033)
o Research Institutes
o Pharmaceutical Companies
o Biotechnology Companies
o Others
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players Insights
o Pfizer Inc.
o GlaxoSmithKline LLC
o Merck & Co. Inc.
o Agilent Technologies Inc.
o Eli Lilly and Company
o F Hoffmann-La Roche Ltd
o Bayer AG
o Abbott Laboratories Inc.
o AstraZeneca PLC
o Shimadzu Corp
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Drug Type
Market Snapshot, By Technology
Market Snapshot, By Service
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Drug Discovery Market, By Drug Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Small Molecule Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Biologics Drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
5. Global Drug Discovery Market, By Technology, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o High Throughput Screening
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Biochips
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Bioinformatics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Pharmacogenomics and Pharmacogenetics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Combinatorial Chemistry
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Nanotechnology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Spectroscopy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Metabolomics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Global Drug Discovery Market, By Service, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Drug Metabolism and Pharmacokinetics (DMPK) Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Pharmaceutical Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Chemical Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Biological Services
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
7. Global Drug Discovery Market, By End User, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Biotechnology Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
8. Global Drug Discovery Market, By Region, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Service, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
o North Africa
o Central Africa
o South Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Pfizer Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GlaxoSmithKline LLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Merck & Co. Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Agilent Technologies Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Eli Lilly and Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
F Hoffmann-La Roche Ltd
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Bayer AG
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Abbott Laboratories Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AstraZeneca PLC
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Shimadzu Corp
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
10. Section
o References
o Research Methodology
o About Us
圖表清單 List of Tables & Figures
NA
NA
提及公司
o Pfizer Inc.o GlaxoSmithKline LLCo Merck & Co. Inc.o Agilent Technologies Inc.o Eli Lilly and Companyo F Hoffmann-La Roche Ltdo Bayer AGo Abbott Laboratories Inc.o AstraZeneca PLCo Shimadzu Corp
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們